mcK6A1 serves as an inhibitor of amyloid-beta (Abeta) aggregation, selectively binding to the 16KLVFFA21 fragment of Abeta42, leading to the formation of an extended beta-sheet structure and preventing the formation of Abeta42 oligomers. This compound is valuable for research into Alzheimers disease and other amyloid-related disorders.
Molecular Weight:
1446.65
Formula:
C71H99N17O16
Target:
Beta Amyloid
TP3044
* VAT and and shipping costs not included. Errors and price changes excepted
